• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Primary Cells

Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated)

  • For research use only

Cat No.

ABC-TC3948

Product Type

Blood Products

Cell Type

Plasma

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Multiple Myeloma

Storage

Liquid Nitrogen

Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) provides clinically relevant samples for biomarker discovery and therapy studies.

Product Image

Description

Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) is derived from the bone marrow of donors newly diagnosed with multiple myeloma and naive to systemic therapy. This plasma is cryopreserved immediately after collection. Functionally, this product exhibits in vitro activities associated with tumor-stromal interactions and angiogenesis, recapitulates key features of the myeloma bone marrow microenvironment, and displays elevated levels of pro-inflammatory cytokines (e.g., IL-6) and monoclonal proteins. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.​

Product Code

Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated), MM BM Plasma, Untreated Myeloma Bone Marrow Plasma, Newly Diagnosed MM BM Plasma

Species

Human

Cat.No

ABC-TC3948

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Plasma

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Multiple Myeloma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Blood Products

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) serves as a physiologically relevant in vitro model for investigating the cellular and molecular mechanisms and disease-associated cellular processes of multiple myeloma. By analyzing its cytokine profiles, autoantibody content, and impact on bone marrow stromal cell interactions, researchers can deeply explore molecular mechanisms driving disease initiation, supporting discovery research and target identification related to multiple myeloma.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button